IIM
ELDN icon

INTECH Investment Management’s Eledon Pharmaceuticals ELDN Stock Holding History

INTECH Investment Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.6K Sell
19,434
-897
-4% -$3.26K ﹤0.01% 1990
2026
Q1 		$62.6K Sell
20,331
-2,519
-11% -$5.93K ﹤0.01% 1979
2025
Q4 		$34.5K Sell
22,850
-3,050
-12% -$7.25K ﹤0.01% 2289
2025
Q3 		$67.1K Sell
25,900
-3,276
-11% -$9.58K ﹤0.01% 2340
2025
Q2 		$79.1K Buy
+29,176
New +$87.5K ﹤0.01% 2345

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

INTECH Investment Management's ELDN Position: Q2 2026 in Review

INTECH Investment Management reduced its Eledon Pharmaceuticals (ELDN) stake by 4.4% in Q2 2026, selling an estimated $3.26K and leaving 19,434 shares worth $76.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1990.

INTECH Investment Management first reported a position in ELDN in Q2 2025 and has held it in 5 quarters since. The position peaked at $79.1K in Q2 2025. 160 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • INTECH Investment Management held 19,434 shares of Eledon Pharmaceuticals worth $76.6K as of Q2 2026.
  • INTECH Investment Management sold 897 Eledon Pharmaceuticals shares in Q2 2026, an estimated $3.26K.
  • Eledon Pharmaceuticals made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1990 holding.
  • INTECH Investment Management first reported a position in Eledon Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • INTECH Investment Management's Eledon Pharmaceuticals position peaked at $79.1K in Q2 2025.
  • 160 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.